[ad_1]
HERMES PARDINI INSTITUTE S / A
CNPJ / MF No. 19.378.769 / 0001-76
No. 3130009880-0
RELEVANT
Belo Horizonte, July 9, 2018 – The L & # 39; Hermes Pardini Institute SA (B3: PARD3) (hereinafter "Company") informs its shareholders and the market that at that date the Board of Directors approved the acquisition by the Company of 55.0 % (fifty-five share capital of Psychemedics Brasil Exams Toxicológicos Ltda. ("Psychemedics Brasil"), a limited liability company, registered with the CNPJ / MF under number 08.075.074 / 0001-07, whose head office is located in Santana do Parnaíba, State of São Paulo, for R $ 45.2 million, which is the subject of contractual adjustments ("Acquisition") .The contractual instruments concluded by the parties allow the Company to Acquire the entire share capital of Psychemedics Brasil during the fourth year of the year. Acquisition.
Psychemedics Brasil has a relevant presence in the Brazilian market for toxicological examinations with a wide detection window. accredited collection units in nearly 1,000 municipalities and a base of more than 10,000 corporate clients. During its 17 years of operation, Psychemedics Brasil has achieved scientific, marketing and social relevance. The samples collected by Psychemedics Brazil are processed by Psychemedics Corporation in the United States, considered one of the world's most advanced private toxicology centers. During the fiscal year ended December 31, 2017, Psychemedics Brasil recorded a cumulative business turnover of about R $ 132 million.
This acquisition fits in the strategy of consolidation, by acquisitions, of the presence of the Pardini Group in the segment The effective transfer of the participation in the Company and the financial settlement of the value of the Acquisition are subject to compliance with the conditions precedent that are generally applicable in this type of operation. , including the approval of the acquisition by the Administrative Council of Economic Defense ("CADE") and, where appropriate, the approval of shareholders of the Company.
The Company will keep the market informed of the next steps of the acquisition, including approvals
Sincerely,
Camilo de Lelis Maciel Silva [194590] 03] Administrative, Financial and Relationship Officer investors
Hermes Pardini Institute
Phone: +55 (31) 3629-4503
[email protected]
http://www.hermespardini.com.br/ri
Website Web: https://ri.hermespardini.com.br
Dino
This is a commercial content published by Dino and is not the responsibility of Terra
[ad_2]
Source link
